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A B S T R A C T
Background: Adipose-derived Stem Cells (ASCs) present great potential for reconstructive procedures. Currently,
isolation by enzyme digestion and culturing using xenogenic substances remain the gold standard, impairing
clinical use.
Methods: Abdominal lipo-aspirate and blood samples were obtained from healthy patients. A novel mechanical
isolation method for ASCs was compared to (the standard) collagenase digestion. ASCs are examined by flow-
cytometry and multilineage differentiation assays. Cell cultures were performed without xenogenic or toxic
substances, using autologous plasma extracted from peripheral blood. After eGFP-transfection, an in vivo dif-
ferentiation assay was performed.
Results: Mechanical isolation is more successful in isolating CD34+/CD31−/CD45−/CD13+/CD73+/CD146−
ASCs from lipo-aspirate than isolation via collagenase digestion (p <0 .05). ASCs display multilineage differ-
entiation potential in vitro. Autologous plasma is a valid additive for ASCs culturing. eGFP-ASCs, retrieved after
3 months in vivo, differentiated in adipocytes and endothelial cells.
Conclusion: A practical method for human ASC isolation and culturing from abdominal lipo-aspirate, without the
addition of xenogenic substances, is described. The mechanical protocol is more successful than the current gold
standard protocol of enzyme digestion. These results are important in the translation of laboratory-based cell
cultures to clinical reconstructive and aesthetic applications.
1. Introduction
The ultimate goal in plastic reconstructive surgery is to replace like
with like. Implant material is prone to complications, and autologous
reconstruction is restricted by tissue scarcity or donor site morbidity.
Adipose-derived stem cells (ASCs) are first described by Zuk et al.
(2002). Since there are about 100 times more ASCs in adipose tissue
than mesenchymal stem cells (MSCs) in bone marrow, and the cells
have a greater potential for proliferation (Lee et al., 2004), there is an
enormous interest in these cells for autologous cell therapy (Banyard
et al., 2015; Trepsat, 2009; Puissant et al., 2005) as well as tissue-en-
gineering experiments (Correia et al., 2012; Guilak et al., 2004; Hong
et al., 2005). They can be easily obtained through liposuction of
subcutaneous adipose tissue, a minimal invasive procedure. Classically,
the lipo-aspirate is then enzymatically digested to isolate the stromal
vascular fraction (SVF) from the buoyant adipocytes. There are many
different enzymatic products available, such as trypsin, clostripain or
dispase, the gold standard being collagenase (from Clostridium histoly-
ticum).
Despite the efficiency of this isolation method, significant draw-
backs (i-v) are incurred with the use of these xenogenic products for
SVF and/or ASCs isolation in human clinical trials. Risks inherent to the
manufacturing process of enzyme products should be considered: (i)
inconsistency in protease activity and (ii) batch-to-batch variations.
Regarding patient safety, potential risks with enzymatically isolated
SVF/ASCs samples administered to humans include (iii) residual
https://doi.org/10.1016/j.scr.2019.101532
Received 26 May 2019; Received in revised form 22 July 2019; Accepted 7 August 2019
⁎ Corresponding author at: 2K12C Gent University Hospital, Corneel Heymanslaan 10, 9000 Gent, Belgium.
E-mail addresses: Maarten.Doornaert@UGent.be (M. Doornaert), Elisabeth.DeMaere@UGent.be (E. De Maere), Julien.Colle@Ugent.be (J. Colle),
Heidi.Declercq@UGent.be (H. Declercq), Joachim.Taminau@irc.UGent.be (J. Taminau), Kelly.Lemeire@irc.UGent.be (K. Lemeire),
Geert.Berx@irc.vib-ugent.be (G. Berx), Phillip.Blondeel@UGent.be (P. Blondeel).
Stem Cell Research 40 (2019) 101532
Available online 08 August 2019
1873-5061/ © 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
collagenase activity (Raposio et al., 2014) and (iv) transferring xeno-
antigens into the patient. Further, (v) manipulation of lipo-aspirate via
enzymatic digestion may alter or disrupt cell surface receptors, which
may reduce the regenerative potential of the SVF (Guo et al., 2015;
Olenczak et al., 2017).
Although recently a human trial with clinical grade collagenase (NB
6 GMP grade, SERVA Electrophoresis GmbH, Heidelberg, Germany) has
been performed (Kølle et al., 2013), mechanical isolation methods have
been developed to overcome these risks. However, these methods in-
cluding sonication (Amirkhani et al., 2016; Packer et al., 2018), explant
culture (Priya et al., 2014) and centrifugation protocols (Shah et al.,
2013; Condé-Green et al., 2010; Markarian et al., 2014) have failed to
deliver a similar yield in ASCs as enzyme digestion.
Standard media for culture and proliferation of the ASCs are α-
modified Eagle's medium (αMEM), Dulbecco's MEM (DMEM) and
McCoy medium. Culture conditions however, as highlighted by Caplan
et al. (Lennon et al., 1995), need an addition to the basic medium to
ensure adhesion and proliferation of ASC's. Classically, ASCs are cul-
tured with fetal bovine serum (FBS), in concentrations varying from 10
to 20%.
To ensure the highest possible safety for patients, all steps of au-
tologous ASC isolation and culture should be precisely defined and
reproducible, thereby eliminating xenogenic substances. Therefore, we
aim to create a useful, high-yield isolation and culture method, com-
posed without xenogenic additives. Further, we assess the regenerative
potential of the xenogen-free isolated ASCs in vivo by analyzing eGFP-
transfected ASCs, 90 days after transplantation into immunodeficient
mice.
2. Materials and methods
2.1. Isolation of ASCs and culture in autologous medium
All procedures were carried out in accordance with the UZ Gent
guidelines and regulations, and all experimental protocols were ap-
proved by the UZ Gent ethical committee. After obtaining written in-
formed consent from all included patients using an UZ Gent ethical
review board-approved protocol, adipose tissue was acquired from
healthy female patients (n=7) undergoing liposuction of the abdomen
between 35 and 50 years of age (mean age 42.3; mean BMI: 28.7).
During the procedure, 50mL of peripheral blood was drawn from each
patient, and 100 IU of heparin were added. After infiltration with
Klein's solution, a 3-mm blunt cannula (Mentor, Santa Barbara, Cal,
USA) was used in combination with device aspiration at −1.5 atm. The
lipo-aspirate was centrifuged in 10mL Luer-Lok™ syringes (Becton
Dickinson, Franklin Lake, NJ, USA) at 3000 rpm for 1min. After cen-
trifugation, the oily and fluid phases were discarded, and the fat graft
was transferred to produce 8 syringes filled with exactly 10mL cen-
trifuged fat. Next, the syringes were randomly assigned: 40mL of fat
graft was then processed according to a classic enzyme digestion pro-
tocol with collagenase (Collagenase-isolated Adipose-derived Stem
Cells; cASCs), and 40mL according to our new mechanical protocol
(Mechanically isolated Adipose-derived Stem Cells; mASCs).
For enzyme digestion isolation a sterile filtered aliquot of col-
lagenase type I 0.3% (Sigma-Aldrich, St. Louis, MO, USA) in Phosphate
Buffered Saline (PBS), and 1% penicillin/ streptomycin (P/S) (Thermo
Fisher, Waltham MA, USA) was added. The mixture was incubated for
45min at 37 °C on a shaker at 15 rpm. FBS was added to a final con-
centration of 10% to stop enzyme activity, followed by centrifugation at
1000 rpm for 5min. The overlying fluid and adipose phases were as-
pirated and discarded. The SVF pellet was resuspended in culture
medium.
For mechanical isolation, a 10mL syringe filled with 5mL fat graft
was connected Luer-to-Luer with another 10mL syringe filled with
5mL PBS and mixed. The mix was forcefully pushed back-and-forth 30
times and emulsified. The resulting 80mL of PBS-diluted, emulsified fat
graft was then centrifuged again at 3000 rpm for 10min.
The blood samples were processed to extract plasma. The samples
were centrifuged at 4000 rpm for 10min, after which the supernatant
plasma, without the buffy coat, was obtained. Culture medium was
created with 90% DMEM-hepes (Sigma-Aldrich, St Louis, MO, USA),
10% human plasma, 1% P/S and 100 IU of heparin. Both the cASCs and
mASCs were cultured at 37 °C and 5% CO2 in an incubator. After 48 h,
the medium was replaced to sort the cells for adherence. After 3 more
days, the medium was replaced again.
2.2. Cell count
After 8 days of culture, cells were released using TrypLE Select
(Thermo- Fisher, Waltham MA, USA). The P1 viable cells of both the
mASC and the cASC group were counted using propidium iodide
(Sigma-Aldrich, St Louis, MO, USA) and resuspended in PBS for flow-
cytometric analysis or replated for multiple lineage differentiation as-
says.
2.3. Flowcytometric analysis
Flowcytometric analysis of the collected cell cultures was performed
(n=7). To identify different (sub)populations, samples of the isolated
cell populations were labeled for specific phenotypic markers.
Following subpopulations were identified: (i) CD34+ progenitor
cells (ii) pre-adipocytes, defined as CD34+/CD45−/CD31−/CD146−,
(iii) transitional cells, defined as CD34+/CD45−/CD31−/CD146+, (iv)
EPCs, defined as CD34+/CD45−/CD31+/CD146+ and (v) true ASCs,
defined as CD34+/CD31−/CD45−/CD13+/CD73+/CD146−.
Samples of collected cASCs and mASCs were labeled with CD34-PE,
CD45-VioGreen, CD31-APC, CD13-APC-Vio700, CD73-PE-Vio770, and
CD146-VioBright515, purchased from Miltenyi Biotec (Bergisch
Gladbach, Germany). Samples were acquired on a four-laser flowcyto-
metry system (BD LSR II, Becton-Dickinson, Franklin Lake, NJ, USA).
Fc-receptor reagent was added to avoid unspecific labelling of cells via
Fc-receptors.
2.4. Differentiation assays
A part of the cASCs and mASCs were seeded on thermanox cover
slips (Nunc, Roskilde, Denmark) for trilineage differentiation.
Adipogenic differentation was performed using basic culture medium
with addition of dexamethasone, insuline, indomethacine and 3-iso-
butyl-1-methylxanthine (Sigma-Aldrich, St Louis, MO, USA).
Differentiation was confirmed by Oil Red O staining. Osteogenic dif-
ferentiation was performed using basic culture medium with addition of
dexamethasone, ascorbic acid and β-glycerophosphate (Sigma-Aldrich,
St Louis, MO, USA). Differentiation was confirmed by Von Kossa
staining. Chondrogenic differentiation was performed using
Chondromax® medium (Sigma-Aldrich, St Louis, MO, USA) in pellet
cultures. Differentiation was confirmed by Alcian blue staining, com-
bined with Hematoxyline-Eosine staining (H-E staining). Digital ima-
ging was performed using an Olympus inverted microscope, and Cell^M
software (Olympus Europe, Hamburg, Germany).
2.5. eGFP-transduction of ASCs
To enable tracking of the ASCs during the in vivo experiment, eGFP-
transduction of the ASCs was performed as described before. 293 T cells
were cultured in DMEM (41965039, ThermoFisher) with 10% FCS and
2mM L-Glutamine (BE17-605F, Lonza) and transfected with lentiviral
envelope plasmid pMD2.G, packaging plasmid psPAX2 and lentiviral
eGFP expression plasmid pLenti6-eGFP. The medium was removed and
replaced with fresh medium 8 h post transfection. The virus was har-
vested 48 h post transfection and filtered through a 0.45 μm PES filter
(Merck- Millipore, Burlington, Massachusetts, USA). P1 mASCs were
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cultured in DMEM with 10% FCS and 2mM L-Glutamine until a density
of approximately 60% was reached. The medium was removed and
replaced by pLenti6-eGFP virus containing medium for 24 h. After
10 days the eGFP positive cells were sorted with the BD FACSAria III
cell sorter. This resulted in 45.3% eGFP-positive ASCs before sorting,
and 95% after sorting.
2.6. Animal model
On the day of the in vivo experimental procedure, abdominal sub-
cutaneous adipose tissue was again obtained via an aesthetic liposuc-
tion procedure in a healthy female (age 30 years), as described above.
50 mL of fat graft was digested with collagenase as described above.
Now, the overlying adipose phase was carefully isolated from the di-
gested fat graft mixture. 10 Eight-week-old T-cell deficient nude mice
(BALB/c-nude; Envigo, Huntingdon, UK) were used in this study. All of
the surgical instruments were sterilized, and surgical procedures were
performed under laminar flow. Immediately before the procedure, 5 mL
peptide hydrogel was gently mixed with 5×105 eGFP-positive ASCs in
250 μL PBS and 5mL mature adipocytes (eGFP-ASC/adipocyte con-
struct). Animal anaesthesia was achieved with isoflurane vaporizer
3.5% for induction, and 1% for maintenance, with non-rebreather
mask. After anaesthesia, the surgical site on the mouse skin was ster-
ilized with chlorhexidin digluconate 0.5% in aqua. A skin puncture was
made with a 19-gauge needle, and 1mL of eGFP-ASC/adipocyte con-
struct was placed subcutaneously on the dorsal side. The puncture
wounds were covered with poly-urethane bandage (Tegaderm®, 3M,
Minneapolis, US).
2.7. Histology
After 90 days, the mice were sacrificed, and the eGFP-ASC/adipocyte
constructs were carefully dissected out. 5 μm-paraffin sections of the
grafts were made through the centre area. The areas composed of
signet-ring cells indicating reticular fat tissue were evaluated on 5
sections through the largest diameter region of the spherical constructs.
Additionally, sections from the eGFP-ASC/adipocyte constructs were
examined with GFP staining: tissue sections were deparaffinized and
rehydrated. Antigen retrieval was performed by heating the sections in
10mM sodium citrate buffer (pH 6.0) (Vector laboratories, Burlingame,
US) in an electric pressure cooker. Blocking of endogenous peroxidase
occurred in 3% H2O2 in methanol. Sections were then treated with 5%
goat serum in PBS+ 1% BSA, followed by an overnight incubation with
primary GFP-antibody (Clone D5.1, Cell Signalling Technology, US) at
4 °C. Detection was done with a biotin-conjugated secondary antibody
followed by Avidin-Biotin complex (ABC) and developed with diami-
nobenzidine (DAB) (Vector Laboratories, Burlingame, US). The sections
were stained with H-E staining and photographed by light microscopy
(Olympus BX50, Hamburg, Germany). The scores were determined by
two independent reviewers using ImageJ software (National Institutes
of Health, Maryland, USA).
For control, we also performed immunofluorescent staining with the
following primary antibodies: rabbit anti-human perilipin (dilution
1:1000; Invitrogen, PA5-55046) and chicken anti-eGFP (dilution 1:50;
Abcam, ab13970), incubated overnight at 4 °C. The following sec-
ondary antibodies were used: For perilipin, Alexa-fluor 555-conjugated
donkey anti-rabbit (dilution 1:500, Thermo Fisher, A31572) incubated
for 30min at room temperature. For GFP, detection was done with a
biotinylated secondary antibody (dilution 1:200, Abcam, ab6876), for
30min at room temperature, followed by incubation with third anti-
body Streptavidin/HRP (dilution 1:200, Dako, P0297) for 30min at
room temperature.
The sections were viewed and photographed with fluorescence mi-
croscopy, and Cell^M software (Olympus Europe, Hamburg, Germany).
2.8. Statistical analysis
Statistical analysis was performed on isolated cASCs and mASCs of 7
patients (n=7). The following outcomes were recorded via cell counts
and quantitative flowcytometric analysis for both isolation methods: (i)
Total (absolute) number of isolated cells, (ii) Percentage of CD34+
cells, (iii) Percentage of 4 subsets of cells (pre-adipocytes, transitional
cells, pericytes and true ASCs). Statistical analysis determined whether
there was a significant difference in the cell-yield between the two
procedures, for the outcomes listed above. A Wilcoxon signed rank test
was carried out using SPSS Statistics 24. This is the non-parametric
version of the paired student's t-test, testing the null hypothesis that
within each patient, there is (on average) no difference in outcome




Cell cultures in medium supplemented with autologous plasma were
without adverse events. After 48 h both cASCs and mASCs became
spindle-shaped and started rapid expansion. Although there was a large
inter-patient variability in cell yield, a higher cell count was found in all
samples of the mASC group, significant at a 5% level (p= .018). After
8 days of cell culture, median cell count was 3.0×105 cells
(min.4.0× 104-max.6.0× 105) in the cASC group and 1.2× 106
(min.2.0× 105-max.4.0× 106) in the mASC group (Table 1) (Fig. 1).
3.2. Flowcytometric analysis
Flowcytometric analysis via population-specific phenotypic markers
showed a larger number of CD34+ cells in the mASC group, significant
at a 5% level (p=0.028) (Fig. 1). Median percentage of CD34+ cells
found in cASC is 4.7% (min.0.7%–max.19.8%) as minimum and max-
imum percentage resp.), median percentage of CD34+ cells found in
mASC is 21.3% (min.2.8%-max.62.1%) (Table 2).
Different subpopulations (pre-adipocytes, transitional cells, EPCs
and true ASCs) were investigated to detect the presence of specific
progenitor cells. The yield of primary culture pre-adipocytes and true
ASCs was larger in the mASC group than in the cASC group, significant
at a 5% level (p= 0.028 for both subpopulations) (Table 2) (Fig. 1).
There was no significant difference in yield of primary culture
transitional cells and EPC cells (Data not shown).
3.3. Differentiation potential
Trilineage differentiation potential of the ASCs was evaluated with a
standard in vitro differentiation assay. Both the cASCs and the mASCs
displayed similar differentiation potential to adipose, osteogenic and
chondrogenic lineage (Fig. 2). Adipogenic differentiation became ob-
vious after 1 week, with cells transforming into a round shape, and
presence of cytoplasmatic lipid droplets as confirmed by Oil Red O
staining. Osteogenic differentiation occurred more slowly over 3weeks'
time, with presence of calceiform material, stained by Von Kossa's stain.
Chondrogenic differentiation also occurred over 3 weeks' time, with
Table 1
Descriptive statistics of the Total cell count for collagenase-isolated and the
mechanically isolated samples (n=7). Cell count was significantly higher in
the mASC group.
Sample Median Minimum Maximum
Collagenase total cell count (×103 cells) 300 40 600
Mechanical total cell count (×103 cells) 1200 200 4000
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Alcian blue staining the sulfated proteoglycans.
3.4. Assessment of the fat graft in vivo
Grafts were harvested after 90 days. Overall graft retention was
poor. The average volume of the eGFP-ASC/adipocyte construct was
0.015 ± 0.009mL, with on average 30% viable fat tissue and large oil
cyst formation. On H-E staining, large cyst formation was observed, as
well as reticular adipose tissue composed of signet-ring like cells, con-
nective tissue and blood vessels with red blood cells in the lumen
(Fig. 3). No foreign material was visualized. Interestingly, all retrieved
adipocytes in the eGFP-ASC/adipocyte constructs stained positive for
DAB, suggesting that no grafted adipocytes or differentiated adipocytes
from the recipient were present. By evaluating sequential 5 μm coupes
by H-E and DAB-staining, vascular structures were found to be deli-
neated by both DAB-positive and DAB-negative stained cells. The cyst
walls were monocellular and equally composed of DAB-positive and
DAB-negative stained cells. These findings were confirmed by im-
munofluorescent staining for perilipin, a specific staining for viable
adipocytes, and for eGFP (Fig. 4).
4. Discussion
We present a novel and practical method for human ASC isolation
and culture from abdominal adipose tissue. The isolation protocol de-
livers large numbers of ASCs in 8 days, without the addition of xeno-
genic substances, thus further closing the gap between laboratory-based
tissue engineering assays and their clinical application. Furthermore,
we compare this novel isolation method to the gold standard, col-
lagenase digestion, and find it to be more efficient in ASC yield for
autologous plasma-supplemented culture.
However, large variations in harvested stromal cell counts are seen
between the included patients, as described before by other groups
(Bellei et al., 2017).
To avoid biases, only patients undergoing abdominal liposuction are
included in the study. Not included in the study are two patients (fe-
male, ages 45 and 48) with lipoedema of the legs for which liposuction
was performed, and two healthy patients who had liposuction of the
flanks and the upper thighs. In these four patients, despite an identical
experimental protocol, mechanical isolation does not appear to be su-
perior to collagenase digestion. Therefore, further research is needed to
explain the large variability in stromal cell harvest between patients,
and the success of our method in other indications or anatomical re-
gions.
In the pioneering works of Friedenstein et al. (1966), Caplan (1991)
and Owen (1988), isolation, culture and osteogenic differentiation of
bone marrow-derived progenitor cells are described, and a new re-
search field for mesenchymal stem cells (MSCs) is unveiled. Twenty
years later, the presence of MSCs is described in nearly all adult tissues,
including adipose tissue: adipose-derived stem cells (ASCs) (Baer and
Geiger, 2012).
The International Society for Cellular Therapy (ICTS) suggests that
the term ‘ASCs’ is used only for the subset of progenitor cells that meets
three minimal criteria: (i) plastic adherence, (ii) expression of CD34+/
CD45−/CD31−/CD13+/CD73+/CD90+, (iii) trilineage differentiation
potential. These criteria are stated in a conjoined effort with the
International Federation for Adipose Therapeutics (IFATS) in 2013
(Dominici et al., 2006).
Currently, there is evidence that ASC preparations are hetero-
geneous cell cultures comprising subsets of stem cells and more dif-
ferentiated progenitor cells, the first presenting very attractive candi-
dates for clinical applications to repair or regenerate damaged tissues,
and tissue engineering purposes.
With regard to cellular composition and therapeutic potential, it is
important to emphasize the difference between the stromal vascular
fraction (SVF) and the ASCs (sub)population(s) after culturing. Some
studies report results attributed to ‘ASCs’ while in fact the SVF is used
and not isolated, cultured stem cells. Although the rationale behind the
use of SVF preparations in those studies relies on the presence of stem
cells within this fraction, it is known that the SVF contains a diminutive
percentage of stem cells among various other cell populations (Dykstra
et al., 2017). Therefore, it is valuable to define what cellular product(s)
are examined when reporting on new research. This may lead to more
adapted and varied tools for cell-based therapies, whereby autologous
regenerative cells or cell populations are selected according to the
procedural indication (Guo et al., 2015). In this study, both mASCs and
Fig. 1. Graphs a-d. a. Total cell count of the col-
lagenase (left) versus the mechanical cultures (right)
of all patients (n=7). After 8 days of cell culture,
median cell count was 3.0×105 cells in the cASC
group and 1.2× 106 in the mASC group. A higher
cell count was found in all samples of the mASC
group, significant at a 5% level.
b.–d. Percentage of b. ASCs (CD34+/CD31−/
CD45−/CD13+/CD73+/CD146−), c. CD34+
stromal cells and d. Preadipocytes, present in the
collagenase (left) versus the mechanical cultures
(right) of all patients (n= 7). For all 3 subpopula-
tions, a significant higher cell-yield was found in the
mASCs group (p < .05).
Table 2
Descriptive statistics of different subpopulations (CD34+, pre-adipocytes, true
ASCs) present in collagenase-isolated and mechanically isolated samples
(n=7). For all 3 subpopulations, a significantly higher cell-yield was found in
the mASCs group.
Sample Median Minimum Maximum
cCD34+ (%) 4.7 0.7 19.8
mCD34+ (%) 21.3 2.8 62.1
cPreadipocytes (%) 3.5 0.7 5.0
mPreadipocytes (%) 11.4 2.8 31.3
cASCs (%) 3.4 0.9 19.4
mASCs (%) 17.4 3.2 55.0
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cASCs are plastic adherent and are able to differentiate into adipose,
osteogenic and chondrogenic lineages. Besides a larger cell yield in the
mASC group, significantly more true ASCs (CD34+/CD31−/CD45−/
CD13+/CD73+/CD146−) are present in the cultures.
To assess the regenerative potential of the mASCs in vivo, we co-
transplanted mASCs with mature adipocytes into immunodeficient
mice. To recover the mASCs after 90 days in vivo, they are transfected
with eGFP, enabling us to distinguish host tissue from donor mASCs
after the mice are sacrificed.
Previously published research from our group has demonstrated
that co-culture of ASCs and mature adipocytes incite proliferation and
adipogenic differentiation in vitro of ASC (Doornaert et al., 2012), hence
the idea of co-transplantation. However, isolation of mature adipocytes
is again performed via collagenase digestion of lipo-aspirate and col-
lection of the buoyant fraction of the adipocytes. Mature adipocytes are
fragile cells, difficult to manipulate and to our knowledge, enzymatic
isolation is the only feasible method for isolation of mature adipocytes.
Ongoing research of our group focuses on a stabilizing carrier gel,
supporting adipogenic (and angiogenic) differentiation, for co-injection
with the ASCs (Van Nieuwenhove et al., 2017; De Moor et al., 2018).
This would render the use of mature adipocytes obsolete.
After 90 days, eGFP-ASCs are retrieved as having differentiated into
mature adipocytes and endothelial cells. These findings further support
the effectiveness of our method to isolate and culture true ASCs.
Furthermore, our in vivo study supports the graft replacement theory, as
documented by Eto, Yoshimura et al. (Eto et al., 2012; Doi et al., 2015).
Fig. 2. Trilineage differentiation assays. Inverted
microscopy, magnification 10×. Left column: cASCs
cultures, Right column: mASCs cultures.
a. cASCs culture day 8, light microscopy b. cASCs
adipogenic differentiation day 10, Oil Red O
staining: detection of cytoplasmatic lipid-filled va-
cuoles (Red) c. cASCs osteogenic differentiation day
24, Von Kossa staining: detection of extracellular
mineralization (Black) d. cASCs chondrogenic dif-
ferentiation day 21, Alcian blue & Hematoxyline-
Eosine staining (H-E staining) (Fuchsia): detection of
extracellular GAGs (Blue) e. mASCs culture day 8,
light microscopy f. mASCs adipogenic differentiation
day 10, Oil Red O staining g. mASCs osteogenic
differentiation day 24, Von Kossa staining h. mASCs
chondrogenic differentiation day 21, Alcian blue &
H-E staining. (For interpretation of the references to
colour in this figure legend, the reader is referred to
the web version of this article.)
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Hong et al. co-transplant donor ASCs from DsRed-expressing mice with
donor fat from GFP-expressing mice into recipient mice to trace the
eventual fate of donor cells in the graft. They find that newly differ-
entiated fat from donor DsRed-ASCs and surviving donor GFP-fat in-
tegrate with recipient tissue. They also describe donor ASCs to parti-
cipate in new vessel formation (Hong et al., 2018). These results
corroborate those of Fu et al., who also find convincing evidence that
the donor SVF cells participate in adipogenesis and angiogenesis (Fu
et al., 2013). It must be noted that these findings indicate that the true,
in vivo potential of human ASCs lies far beyond their defining, in vitro
criteria as described by the ICTS and IFATS.
We have adopted the idea of inter-syringe shuffling from Tonnard
et al., who apply this processing step to create Nanofat (Tonnard et al.,
2013). Their protocol focuses on clinical applications, creating a fat
graft with fat particles sufficiently small for a controllable injection
through fine cannulas.
In search for a mechanical isolation protocol for ASCs, Chaput et al.
describe a lesser yield of nucleated cells with inter-syringe processing
compared to enzyme digestion (Chaput et al., 2016). Inter-syringe
shuffling is further examined by Banyard et al., who also find a three-
fold upregulation of CD34+ cells, a universal marker of stem cell ac-
tivity, isolated through inter-syringe shuffling (Banyard et al., 2016).
Our protocol differs from the protocols of Chaput et al. and Tonnard
et al. in a number of ways. In this study (i) the lipo-aspirate is cen-
trifuged first to obtain 10mL syringes with identical density lipo-aspi-
rate to allow unbiased comparison between the mASC and cASC groups,
(ii) no filters are used in the process and, (iii) PBS is added to the lipo-
aspirate prior to inter-syringe shuffling. By adding PBS, the efficiency of
centrifugation to separate particles of different mass, size and shape, is
vastly improved. The volume fraction of the solids, the viscosity and the
density difference between the particles and the liquids are altered,
allowing for a more efficient centrifugal release of the stromal cell
pellet.
In the works of Tonnard and Banyard, the shuffled fat grafts are
further subjected to collagenase digestion to analyze, measure and re-
port their resulting ASC yield after processing via inter-syringe shuf-
fling, rather than to provide the ASC yield from the inter-syringe
shuffling per se.
Raposio et al. find a lesser cell yield with mechanical dissociation
with vibrant shaking, compared to collagenase digestion, but no ana-
tomical liposuction regions are mentioned, nor the viability assay that
is used (Raposio et al., 2017). Shah and all find a lesser cell yield by
washing and shaking the adipose tissue, compared to collagenase di-
gestion (Shah et al., 2013).
Fig. 3. Histology of eGFP-ASC/adipocyte constructs
after 3 months in vivo. Light microscopy, Cell^M
software.
a. Magnification 20×, immunohistochemical
staining (IHC staining) for eGFP, visualization with
DAB of eGFP-ASC/adipocyte construct: detail of re-
ticular adipose tissue. Arrow-points: eGFP-positive
adipocytes. Asterixes: Interlying vascular structures,
eGFP-negative.
c. Magnification 40×, IHC staining for eGFP, visua-
lization with DAB of eGFP-ASC/adipocyte construct.
Arrow: vascular structure with inlying red blood
cells, lined by eGFP-positive cells.
b. and d. Magnification 40×, respectively
Hematoxyline-Eosine staining and IHC staining with
DAB of eGFP of subsequent coupes. Arrows: vascular
structures composed of both eGFP-positive and ne-
gative cells. (For interpretation of the references to
colour in this figure legend, the reader is referred to
the web version of this article.)
Fig. 4. Immunofluorescent staining of eGFP-ASC/
adipocyte constructs after 3months in vivo.
Fluorescence microscopy, magnification 40×,
Cell^M software.
a. Staining for viable adipocytes at 3 months with
Perilipin. Primary antibody, rabbit anti-human peri-
lipin (dilution 1:1000), was incubated overnight at
4 °C. Secondary antibody, Alexa-fluor 555-con-
jugated donkey anti-rabbit (dilution 1:500) was in-
cubated for 30min at room temperature.
b. Staining for GFP-positive cells present after
3 months in vivo with primary antibody chicken anti-
eGFP (dilution 1:50), incubated overnight at 4 °C,
biotinylated secondary antibody incubated for
30min at room temperature, followed by incubation
with third antibody Streptavidin/HRP (dilution
1:200) for 30min at room temperature.
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The scientific discussion about the use of collagenase in ASC isola-
tion remains active. Chang et al. describe neutralization of collagenase
activity after several washing steps and non-carcinogenity of resulting
ASCs (Chang et al., 2013). To reduce xenogens, xenogen-free alter-
natives for collagenase exist (Carvalho et al., 2013). However, studies
also describe the adverse effect of collagenase on human adipocytes,
interstitial cell viability, and a very detrimental effect on the fat graft in
general (Olenczak et al., 2017; Seaman et al., 2015). Furthermore, 1 g
of collagenase costs on average $450, expenses which thus can be
saved.
During cell culture, no xenogenic or toxic substances are used, such
as FBS, trypsin or red cell lysis buffer. There are many concerns about
the practicality of FBS-supplemented medium in cell cultures for human
therapeutic approaches, such as infectious complications or host im-
mune reactions (Muller et al., 2006). Others have tested new xenogen-
free media (Muller et al., 2006; Rajala et al., 2007; Parker et al., 2007)
but find significant differences in surface markers. Autologous plasma
however is readily available in large quantities, very cost-efficient, and
does not pose these safety issues. During the experiment the platelet-
containing buffy coat is not included for standardization. However, in
pre-trial experiments, adding of this platelet-rich layer appeared to
cause a strong increase in culture growth (unpublished observation),
corroborating other studies (Masoudi et al., 2016; Schallmoser and
Strunk, 2009).
Because the mechanical extraction and autologous plasma-aug-
mented culture of ASCs is completely xenogen-free, the secretome of
the cultured ASCs is available for clinical purposes. After hypoxic cul-
ture in particular, ASCs are known to secrete a vast array of growth
factors (Braga Osorio et al., 2010).
Any procedure related to Cell-Based Medicinal Products (CBMPs)
requires strict control in a cGMP facility (Giancola et al., 2012). These
facilities are designed and organized according to Good Manufacturing
Practice for Pharmaceutical Manufactures. Quality control and quality
assurance programs control collection, processing, storage and release of
CMBPs developed in these facilities. Among others, all used equipment
and materials are specified, controlled, validated, labeled, risk assessed
and reviewed. Hence, any effort to reduce the involved materials in the
processing is a major cost and time reducing benefit. Furthermore,
major risks to CMBPs include microbiological contamination, loss of
cell function, immunogenicity, toxicity of media. Again, keeping the
procedures simple and close to the clinical practice, vastly reduces these
adverse events.
In conclusion, an easy and practical method for human ASC isola-
tion and culture from abdominal liposuction fat, without the addition of
xenogenic substances, is described. We compare this novel isolation
method to the current gold standard, collagenase digestion, and find it
to be more efficient.
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